Adhera Therapeutics Inc
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is… Read more
Adhera Therapeutics Inc (ATRX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2023: 0.001x
Based on the latest financial reports, Adhera Therapeutics Inc (ATRX) has a cash flow conversion efficiency ratio of 0.001x as of September 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-29.16K) by net assets ($-26.32 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Adhera Therapeutics Inc - Cash Flow Conversion Efficiency Trend (1988–2022)
This chart illustrates how Adhera Therapeutics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Adhera Therapeutics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Adhera Therapeutics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alumex PLC
CM:ALUMN0000
|
N/A |
|
Advanced Container Technologies Inc
PINK:ACTX
|
0.041x |
|
Foothills S.A.
WAR:FTL
|
N/A |
|
Ampio Pharm
PINK:AMPE
|
-0.687x |
|
Patria Private Equity Trust
LSE:PPET
|
-0.001x |
|
BIG RED MINING CORP.
F:K8J
|
N/A |
|
Prism Technologies Group Inc
PINK:PRZM
|
0.033x |
|
Meta Materials Inc.
NASDAQ:MMATQ
|
-0.323x |
Annual Cash Flow Conversion Efficiency for Adhera Therapeutics Inc (1988–2022)
The table below shows the annual cash flow conversion efficiency of Adhera Therapeutics Inc from 1988 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | $-22.19 Million | $-1.42 Million | 0.064x | +140.79% |
| 2021-12-31 | $-25.11 Million | $-665.00K | 0.026x | -33.45% |
| 2020-12-31 | $-14.77 Million | $-588.00K | 0.040x | -95.50% |
| 2019-12-31 | $-9.89 Million | $-8.74 Million | 0.884x | +126.91% |
| 2018-12-31 | $2.93 Million | $-9.61 Million | -3.284x | -16.77% |
| 2017-12-31 | $448.24K | $-1.26 Million | -2.813x | -1633.21% |
| 2016-12-31 | $3.22 Million | $-522.31K | -0.162x | +98.03% |
| 2015-12-31 | $263.00K | $-2.17 Million | -8.232x | -852.91% |
| 2014-12-31 | $-4.37 Million | $-4.78 Million | 1.093x | +2809.95% |
| 2013-12-31 | $-7.06 Million | $285.00K | -0.040x | +99.99% |
| 2012-12-31 | $38.00K | $-16.12 Million | -424.132x | -43242.15% |
| 2010-12-31 | $17.17 Million | $-16.80 Million | -0.979x | -189.55% |
| 2009-12-31 | $-6.89 Million | $-7.53 Million | 1.093x | -91.20% |
| 2008-12-31 | $-3.26 Million | $-40.47 Million | 12.419x | +1148.32% |
| 2007-12-31 | $39.22 Million | $-46.46 Million | -1.185x | -247.99% |
| 2006-12-31 | $43.34 Million | $-14.75 Million | -0.340x | +39.52% |
| 2005-12-31 | $55.57 Million | $-31.28 Million | -0.563x | -70.76% |
| 2004-12-31 | $58.15 Million | $-19.17 Million | -0.330x | +23.20% |
| 2003-12-31 | $17.91 Million | $-7.69 Million | -0.429x | +42.95% |
| 2002-12-31 | $8.64 Million | $-6.50 Million | -0.752x | -37.77% |
| 2001-12-31 | $13.49 Million | $-7.37 Million | -0.546x | +33.56% |
| 2000-12-31 | $9.56 Million | $-7.86 Million | -0.822x | -157.44% |
| 1999-12-31 | $16.60 Million | $-5.30 Million | -0.319x | -213.14% |
| 1998-12-31 | $25.50 Million | $-2.60 Million | -0.102x | +20.66% |
| 1997-12-31 | $24.90 Million | $-3.20 Million | -0.129x | -1616.47% |
| 1996-12-31 | $11.80 Million | $100.00K | 0.008x | -35.59% |
| 1994-12-31 | $7.60 Million | $100.00K | 0.013x | -43.42% |
| 1993-12-31 | $4.30 Million | $100.00K | 0.023x | -73.09% |
| 1992-12-31 | $-810.00K | $-70.00K | 0.086x | -19.75% |
| 1991-12-31 | $-1.30 Million | $-140.00K | 0.108x | -13.02% |
| 1990-12-31 | $-1.05 Million | $-130.00K | 0.124x | -87.08% |
| 1989-12-31 | $-480.00K | $-460.00K | 0.958x | -27.54% |
| 1988-12-31 | $-310.00K | $-410.00K | 1.323x | -- |